Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Satavaptan in cirrhotic ascites
NCT00358878Phase 3Completed
- Sponsor
- Sanofi
- Start
- Jul 2006
- Primary completion
- Dec 2008
- Modality
- Small Molecules
- Countries
- 21
01
Overview
Phase 3, randomised, double-blind trial in ascites comparing Satavaptan with Placebo (2 arms). Primary endpoint: Composite endpoint of ascites worsening at 12 weeks. Started Jul 2006; status: completed.
02
Drugs
satavaptan
03
Conditions
ascites
Beyond the preview
Go deeper on NCT00358878.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00358878.